Department of Internal Medicine
![]() Curt H. Hagedorn, M.D. Division Chief |
Division of Gastroenterology, Hepatology and Nutrition
The Division of Gastroenterology (GI) has nineteen full-time physicians, two physician assistants, one nurse practioner, and eight fellows. The Division focuses on three main enterprises: clinical services, research and education. Curt H. Hagedorn, M.D. serves as the Division Chief, John C. Fang, M.D. as the Clinical Director, and Kevin Dustin, MBA as the Associate Director.
EducationThe University of Utah and Salt Lake City Veterans Affairs Medical Center have the only accredited three-year fellowship program in Gastroenterology in the Intermountain West. Two new positions are offered each year. Approximately 500 new and return patients are seen each month and approximately 900 endoscopic procedures are performed each month. GI Fellows experience a rich training environment with rotations at the University of Utah Medical Center, Salt Lake City Veterans Affairs Medical Center, and Huntsman Cancer Hospital. All areas of GI and hepatology are provided through the fellowship program, including therapeutic endoscopy, liver transplant, motility, and endoscopic ultrasound.
A GI/Hepatology multidisciplinary CME accredited conference is held each week and is open to gastroenterologists, surgeons, pathologists, and radiologists. There is also a monthly research seminar and monthly conferences in GI motility, physiology and radiology. The teaching programs are of the highest quality. The students and residents repeatedly have outstanding scores on national exams and the fellows consistently score well on subspecialty board exams.
Administration Research
The research interests of the Division are extensive and include: tumor biology, genetics of GI cancers, hepatitis C, mechanisms of drug-induced liver disease, chemoprevention and treatment of GI malignancies, gastrointestinal motility disorders, pulmonary complications of gastroesophageal reflux, Helicobacter pylori research, pancreatic cancer, eosinophilic esophogitis, irritable bowel syndrome, and esophageal cancer.

